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Abstract: 
Invasive fungal opportunistic infections or mycoses have been on the rise with increase in the number of immuno-compromised 
patients accounting for associated high morbidity and mortality rates. The antifungal drugs are not completely effective due to 
increased resistance and varied susceptibility of fungi. Hence, the functional diversification study of novel targets has to be carried 
out. The enzyme glucosamine-6-phosphate synthase [EC 2.6.1.16], a novel drug target, catalyzes the rate-limiting step of the fungal 
cell-wall biosynthetic pathway, comprising four conserved domains, two glutaminase and sugar-isomerising (SIS) domains with 
active site. The amino acids within these domains tend to mutate simultaneously and exert mutual selective forces which might 
result in untoward fungal adaptations that are fixed through random genetic drift over time. The current study is an attempt to 
investigate such ‘non-independent’ coevolving residues which play critical functional and structural role in the protein. Residues 
with Shannon entropy <=1 (calculated by the Protein Variability Server) were considered and subsequently, positional correlations 
were estimated by InterMap3D 1.3 server.  It was observed that majority of coevolving pairs of first SIS domain involved 
interactions with hydrophobic leucine and found to be spatially coupled in 3-dimensional structure of the enzyme. The coevolving 
groups of Aspergillus niger and  Rhizopus oryzae species might play a role in drug resistance. Such coevolutionary analysis is 
important for understanding the receptor-ligand interactions and effective drug designing. 
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Background: 
Mycoses or invasive fungal infections such as  Candidiasis, 
Aspergillosis, Histoplasmosis, Coccidioidomycosis, 
Blastomycosis, Penicilliosis, Cryptococcosis and Zygomycosis 
have been on the rise since the past two decades. They are 
caused by fungi belonging to either of the phyla, Ascomycetes, 
Basidiomycetes and Zygomycetes. The fungi afflict patients 
mostly suffering from immunocompromised diseases [1] and 
the existing drugs have limited antifungal spectrum due to 
increased resistance and varied susceptibility of fungi. Hence, it 
is imperative to search for novel antifungal drug targets against 
which an effective lead compound can be generated. The 
enzyme glucosamine-6-phosphate (G-6-P) synthase [EC 
2.6.1.16] acts as a potential antifungal drug target which 
catalyzes the rate-limiting step of the fungal cell-wall 
biosynthetic pathway [2]. It consists of four conserved domains, 
two glutaminase (GATase) and sugar-isomerising (SIS) 
domains with active sites. These domains are highly conserved 
and functional across the mycoses-causing fungi as detected 
from their multiple sequence alignments (MSA) and variability 
analyses within the consensus sequences [3]. However, there 
are probabilities that within these domains, the amino acids 
might get mutated simultaneously. Identification of such ‘non-
independent evolution’ of residues can highlight the 
interactions and subsequent functions among them and this 
motivated us to carry out co-evolutionary study of these 
domains at the molecular level. 
 
Methodology: 
20 amino acid sequences of G-6-P synthase for mycoses-causing 
fungi (Table 1, see Supplementary material) as listed in the 
World Health Organization were retrieved and compiled from BIOINFORMATION  open access 
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Broad Institute of MIT and Harvard 
(http://www.broadinstitute.org/), DOE Joint Genome Institute 
(http://genome.jgi-psf.org/programs/fungi/index.jsf) and 
NCBI fungal databases 
(http://www.ncbi.nlm.nih.gov/projects/genome/guide/fungi
/). These sequences were manually separated according to the 
protein families predicted by PFAM and the variability of the 
individual domains was estimated by the Shannon entropy (H) 
analyses [4] using the Protein Variability Server. Subsequently, 
intra-domain co-evolutionary parameters were averaged out 
throughout the MSA by InterMap3D 1.3 server [5]. The 
intersection between predictions of 3 methods viz. MI/Entropy 
[6], entropy dependency (RCW-MI) [7] and dependency [8] 
were selected to obtain top 10 coevolving pairs. Only those 
coevolving groups with one or both the residues having H<=1 
were taken into consideration. 
 
 
Figure 1: Representation of intra-domain co-evolutionary pair 
of amino acid (aa) 1 and 2 which corresponds to spatially 
coupled sites at active site of the enzyme. 
 
 
Figure 2: Shannon entropy analyses of all domains of G-6-P 
synthase of mycoses-causing fungi. X-axis represent the 
sequence of domains, Y-axis represent their Shannon 
variability. 
 
Discussion: 
GATase II and SIS domains are the conserved protein families 
of G-6-P synthase obtained from PFAM across mycoses-causing 
fungi. These domains specify the active sites of the enzyme 
which are flexible for mutations. Single mutation can be lethal, 
but if amino acids co-evolve simultaneously, the deleterious 
effect of mutation can be neutrally fixed through random 
genetic drift over a period of time which ideally has no effect 
upon the fitness of the organism. The co-evolutionary pairs 
exert mutual evolutionary pressures on each other leading to 
adaptations such as antifungal drug resistance or varied 
susceptibility of fungi. Hence, investigation of coevolving pairs 
becomes critical for better antifungal drug designing. Figure 1 
represents co-evolutionary pair within a domain where 2 amino 
acids have been mutated; concurrently during evolution they 
tend to play a significant role in the structure and function of 
the enzyme. To begin with Shannon entropy (H) analyses, one 
of the most sensitive tool, was performed to compute variability 
within the domains (Figure 2) and residues with H<=1 have 
been considered because they represent highly conserved 
positions. Subsequently, InterMap3D 1.3 server [5] detected 
intra-domain co-evolutionary pairs (Figure 3) and the same pair 
of residues repeatedly arose from the phylogenetic tree (data 
not shown), implying true and strong co-evolution. The 
coevolving pairs having either one or both the highly conserved 
amino acid residues with H<=1 as shown (Supplementary 
material Table 2).  
 
 
Figure 3: Coevolving pairs of all domains of G-6-P synthase of 
mycoses-causing fungi. X-axis represent the coevolving 
residues, Y-axis represent the distance (Å) between them. 
 
In the first GATase II domain, the coevolving pair at positions 9 
and 14 of Aspergillus niger2 (i.e. Y-N) is not present along with 
the other Aspergillus  species (Y-D). Rhizopus oryzae1 (N-A) is 
separated from the rest of the zygomycetes (N-S) at positions 24 
and 27. In the case of first SIS domain, 50% of the results show 
A. niger2 along with the other Aspergillus species. It is possible 
that the coevolving residues of A.niger2 and R. oryzae1 might 
have an additional functional role viz. increased resistance 
against antifungal drugs. The result is in accordance with our 
previous study [3]. Moreover, most of the coevolving pairs of 
the first SIS domain show interactions with the hydrophobic 
amino acid, leucine. It might be suitable as one of the antifungal 
drug target sites. Coevolving pairs were obtained for the second 
GATase II and SIS domains as well, but none of the amino acids 
had H<=1 because the co-evolutionary residues were lying 
within slightly variable regions which are generally comprised 
of  loop portions of an enzyme structure and known to be 
highly mutable. Consequently, targeting to such sites would not 
be a very good choice. It is also interesting to note that 
coevolving pairs have mostly either hydrophobic-hydrophobic BIOINFORMATION  open access 
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or hydrophobic-hydrophilic type of interactions, directing the 
nature of the antifungal drugs. Furthermore, in the 3-
dimensional structure, the coevolving residues are closer to 
each other, i.e. they are spatially coupled as shown in Figure 4. 
Thus, co-evolutionary relationships might be crucial for 
carrying out enzymatic functions or maintaining its structure, 
but the reverse is not true. Hence, it is vital to consider 
coevolving positions for stronger receptor-ligand interactions to 
come up with an improved lead compound. 
 
 
Figure 4: Spatially coupled coevolving groups identified in the 
domains of G-6-P synthase of mycoses-causing fungi (Pymol 
software used for visualization). a) Domain First GATase I 
(PDBID: 1XFG) with coevolving aminoacids Gln9 & Glu14, 
Glu24 & Gly27, and Asp11 & Glu18. b) Domain First SIS 
(PDBID: 2PUW) with coevolving aminoacids Leu411 & Arg485, 
Thr413 & Arg485, Leu411 & Tyr511, Thr413 & Tyr511, Leu411 & 
Leu514, Thr413 & Leu514, Arg485 & Tyr511, and Arg485 & 
Leu514. 
 
Conclusion: 
Co-evolutionary study of functional domains within G-6-P 
synthase of mycoses-causing fungi was conducted at the 
molecular level to better understand the factors that influence 
the functional and structural aspects of the enzyme, particularly 
the increasing fungal resistance against drugs. Admissible 
changes at one residue alter the selective forces on other amino 
acids; referred to as coevolving pairs. These coordinated neutral 
mutations help in the functional annotations and are spatially 
coupled in the 3-dimensional structure of the enzyme. The 
current study evaluated the coevolving pairs within the 
conserved domains of the enzyme subsequent to estimation of 
their Shannon entropies. This study implies the functional 
diversification of residues at active sites which might be the 
cause for antifungal drug resistance or other untoward fungal 
adaptations in the future. Such analyses could assist in better 
computer-aided drug designing of antifungal drugs. 
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Supplementary material:  
 
Table 1: List of mycoses-causing fungi used in the current study as listed in the World Health Organization. 
Ascomycetes Basidiomycetes  Zygomycetes 
Candida albicans (713aa)  Cryptococcus neoformans (706aa)  Rhizopus oryzae_1 (688aa) 
Candida tropicalis (686aa)    Rhizopus oryzae_2 (688aa) 
Candida dubliniensis (711aa)    Mucor circinelloides (688aa) 
Candida glabrata (723aa)    Phycomyces blakesleeanus (692aa) 
Aspergillus nidulans (898aa)     
Aspergillus fumigatus (694aa)     
Aspergillus flavus (693aa)     
Aspergillus niger_1 (694aa)     
Aspergillus niger_2 (702aa)    
Aspergillus clavatus (694aa)     
Coccidioides immitis (716aa)     
Penicillium chrysogenum (694aa)     
Penicillium marneffei (694aa)     
Blastomyces dermatitidis (694aa)     
 
Table 2: Coevolving  pairs of amino acids identified within the domains of G-6-P synthase of mycoses-causing fungi. AF- 
Aspergillus flavus, AN1- A. niger1, AN2- A. niger2, Afu- A. fumigatus, AC- A. clavatus, Anid- A. nidulans, PM- Penicillium marneffei, 
PC- P. chrysogenum, BD- Blastomyces dermatitidis, HC- Histoplasma capsulatum, CI- Coccidioides immitis, CA- Candida albicans, CD- C. 
dubliniensis, CT- C. tropicalis, CG- C. glabrata, PB- Phycomyces blakes, CN- Cryptococcus neoformans, RO1- Rhizopus oryzae1, RO2- R. 
oryzae2, MC- Mucor circinelloides.  
Coevolving residues in first GATase II domain 
Position Coevolving  residues Fungi  Frequency 
9 & 14  Y-D  AN1,CI,BD,HC,PM,PC,AF,Afu,AC,Anid,PB  0.611 
 F-S  RO1,RO2,MC,CA,CD  0.278 
 Y-S  CG  0.056 
 Y-N  AN2  0.056 
24 & 27  N-S  AN1,CI,BD,HC,PM,PC,RO2,MC,AN2,AF,Afu,AC,Anid  0.722 
 E-Q  CA,CD  0.111 
 N-A  RO1,PB  0.111 
 D-K  CG  0.056 
11 & 18  V-I  AN1,CI,PM,PC,CG,CA,CD,AN2,AF,Afu,AC,Anid,PB  0.722 
 C-V  RO1,RO2,MC  0.167 
 I-I  BD,HC  0.111 
Coevolving residues in first SIS domain 
20 & 94  M-L  AF,AN1,Afu,AC,PM,BD,Anid,HC,CI,PC  0.526 
 L-R  CT,CD,CA,RO1,RO2,MC,PB,CG  0.421 
 V-L  AN2  0.053 
22 & 94  V-L  AF,AN1,Afu,AC,PM,BD,Anid,HC,CI,PC,AN2  0.579 
 T-R  CT,CD,CA,RO1,RO2,MC,PB,CG  0.421 
20 & 120  M-F  AF,AN1,Afu,AC,PM,BD,Anid,HC,CI,PC  0.526 
 L-Y  CT,CD,CA,RO1,RO2,MC,PB,CG  0.421 
 V-F  AN2  0.053 
22 & 120  V-F  AF,AN1,Afu,AC,PM,BD,Anid,HC,CI,PC,AN2  0.579 
 T-Y  CT,CD,CA,RO1,RO2,MC,PB,CG  0.421 
20 & 123  M-M  AF,AN1,Afu,AC,PM,BD,Anid,HC,CI,PC  0.526 
 L-L  CT,CD,CA,RO1,RO2,MC,PB,CG  0.421 
 V-M  AN2  0.053 
22 & 123  V-M  AF,AN1,Afu,AC,PM,BD,Anid,HC,CI,PC,AN2  0.579 
 T-L  CT,CD,CA,RO1,RO2,MC,PB,CG  0.421 
94 & 120  L-F  AF,AN1,Afu,AC,PM,BD,Anid,HC,CI,PC,AN2  0.579 
 R-Y  CT,CD,CA,RO1,RO2,MC,PB,CG  0.421 
94 & 123  L-M  AF,AN1,Afu,AC,PM,BD,Anid,HC,CI,PC,AN2  0.579 
 R-L  CT,CD,CA,RO1,RO2,MC,PB,CG  0.421 
 